Anticoagulation for stroke prevention in new atrial fibrillation after coronary artery bypass graft surgery

17.03.20151493
The benefit of early anticoagulation for stroke prophylaxis in atrial fibrillation after coronary artery bypass graft (CABG) surgery is uncertain.

Beta-blocker therapy and prognosis of heart failure patients with new-onset diabetes mellitus

16.03.20151734
The study aim to assess the effect of bB on the prognosis of heart failure (HF) patients with new–onset diabetes mellitus (DM) treated with a contemporary medical regime.

Patients with rheumatic autoimmune disease at higher risk after MI

13.03.20151373
The risk of mortality was higher in patients with rheumatic autoimmune diseases at 30 days and 12 months following myocardial infarction, and patients faced lower rates of revascularization, according to recently published research.

Medical advice motivates patients to reduce sodium intake

12.03.20151327
U.S. adults who received dietary medical advice were more likely to make changes to monitor or reduce their sodium consumption than adults who were not advised about their consumption, researchers reported in a new study.

Patients with high genetic risk for CHD benefit most from statin therapy

11.03.20151803
Adults with the highest genetic risk for CHD derived the greatest benefits from statin therapy, regardless of traditional risk factors, according to new findings.

CPAP therapy reduces risk for repeat revascularization after PCI

10.03.20151452
Untreated obstructive sleep apnea was associated with an increased risk for repeat revascularization after percutaneous coronary intervention, while continuous positive airway pressure therapy reduced that risk, according to study results.

Paroxetine improves cardiac function in mice after myocardial infarction

05.03.20151449
After noticing that paroxetine, a selective serotonin reuptake inhibitor normally used to treat depression, stopped the progression of heart failure in mice, researchers have concluded that the drug could be reclassified for use in humans, investigators wrote in Science Translational Medicine.
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.